Prevalence of Function-Limiting Late Effects in Hodgkin Lymphoma Survivors
Nabela Enam, Kathy Chou, Michael D. Stubblefield
doi: https://doi.org/10.1101/2020.10.02.20202408
Nabela Enam
1Department of Physical Medicine & Rehabilitation, Rutgers New Jersey Medical School, Newark, NJ, USA
MDKathy Chou
1Department of Physical Medicine & Rehabilitation, Rutgers New Jersey Medical School, Newark, NJ, USA
DOMichael D. Stubblefield
2Kessler Institute for Rehabilitation, West Orange, NJ, USA; Department of Physical Medicine & Rehabilitation, Rutgers New Jersey Medical School, Newark, NJ, USA
MDData Availability
Data for 100 sequential patients previously diagnosed and treated for late effects of Hodgkin Lymphoma was available and included in the study
Posted October 05, 2020.
Prevalence of Function-Limiting Late Effects in Hodgkin Lymphoma Survivors
Nabela Enam, Kathy Chou, Michael D. Stubblefield
medRxiv 2020.10.02.20202408; doi: https://doi.org/10.1101/2020.10.02.20202408
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2986)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12848)
- Forensic Medicine (12)
- Gastroenterology (839)
- Genetic and Genomic Medicine (4652)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2960)
- Health Policy (1076)
- Hematology (394)
- HIV/AIDS (938)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4441)
- Nursing (239)
- Nutrition (653)
- Oncology (2310)
- Ophthalmology (655)
- Orthopedics (260)
- Otolaryngology (328)
- Pain Medicine (286)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1205)
- Primary Care Research (506)
- Public and Global Health (7039)
- Radiology and Imaging (1557)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (387)
- Surgery (494)
- Toxicology (60)
- Transplantation (213)
- Urology (186)